The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Incubator/Accelerator | Alive

About Core Tech Solutions

Core Tech Solutions, Inc. is engaged in the development of Transdermal, Dermal and Tran mucosal Delivery Systems for the treatment of a variety of indications. The primary mission of the company is to provide transdermal drug delivery development to the worlds pharmaceutical companies. In addition to offering research and development on a contractual basis, Core Tech Solutions possesses the facilities and expertise to perform or coordinate all other aspects of commercialization including Feasibility Studies, Prototype Development, Formulation Optimization, Clinical Trials, Regulatory Compliance, Process Scale-up, and Full Scale Manufacturing.

Core Tech Solutions Headquarter Location

50 Lake Drive

East Windsor, New Jersey, 08520,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Core Tech Solutions Patents

Core Tech Solutions has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Acetylcholinesterase inhibitors, Alzheimer's disease, Amines, Organophosphate insecticides, Dosage forms


Application Date


Grant Date



Related Topics

Acetylcholinesterase inhibitors, Alzheimer's disease, Amines, Organophosphate insecticides, Dosage forms



Latest Core Tech Solutions News

Ontogenetic Market 2019-2025: Industry Technology, Recent Development in Market and Key Players Analysis(ANT Neuro, Core Tech Solutions, EMS Handels Gesellschaft, Natus Medical, Ontogeny, Symbiotic Devices)

Jan 29, 2020

Ontogenetic is a developmental history of an organism, which includes the study of cognitive, physical, social, and emotional development, which can be attributed to experience with the individuals and the environment within the environment. Ontogenetic is a vast subject and continuous research in the field is expanding its applications. Increasing human and animal population is one of the major factors affecting the market growth, positively. Furthermore, increasing funding for research is one of the major driving factors of the market. Epilepsy is the disorder of a nervous system. According to the last updated report on February 2017 by World Health Organization (WHO), around 50 million people are affected with epilepsy globally, and it affects people of all ages. Get Sample Copy of this Report: Symbiotic Devices World Ontogenetic Market 2019 Global Industry research report represents the historical overview of current market Situation and forecast 2019-2025. Additionally, this report explorers Ontogenetic market size, trends, share, growth, development plans, Investment Plan, cost structure and drivers analysis. In this Ontogenetic market report, industry trends have been explained on the macro level which makes it possible outline market landscape and probable future issues. The Global Ontogenetic market 2019 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Ontogenetic market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. Inquire more or share questions if any on this report @  The report also focuses on global major leading industry players of Ontogenetic market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Ontogenetic development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With tables and figures helping analyze worldwide Air Cargo Security market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market Order a copy of Ontogenetic Market Report 2019 @

  • Where is Core Tech Solutions's headquarters?

    Core Tech Solutions's headquarters is located at 50 Lake Drive, East Windsor.

  • What is Core Tech Solutions's latest funding round?

    Core Tech Solutions's latest funding round is Incubator/Accelerator.

  • Who are the investors of Core Tech Solutions?

    Investors of Core Tech Solutions include High Technology Small Business Incubator.

  • Who are Core Tech Solutions's competitors?

    Competitors of Core Tech Solutions include Mirus Bio, Brainsgate, AcelRx Pharmaceuticals, PolyPid, Corium International, EZRA Innovations, MonoSol Rx, Sagent Pharmaceuticals, Critical Pharmaceuticals, Capnia and 21 more.

You May Also Like

Next Breath

Next Breath, LLC is a contract pharmaceutical research and development organization dedicated to pre-clinical identification and evaluation of commercially viable respiratory and nasal drug delivery platforms. NB's business will discover and exploit optimal drug and delivery device combinations that will increase the company's partners' probability of success when their products advance into human clinical trials and the marketplace. Next Breath seeks to meet the pharmaceutical industry's outsourcing needs and to provide intellectual expertise to biotechnology companies that are developing inhalation products.

Talima Therapeutics

Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. Our lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials.

Selective Amplifier Genes

Selective Amplifier Genes offers artificial genes that improve the functions of vectors for use in blood disorders


BrainsGate develops a technology for modulation of cerebro-vascular properties through neuro-stimulation of the spheno-palatine ganglion. Affected properties are central to many CNS disorders - blood vessel permeability and blood flow. Currently targeted applications include treatment of ischemic stroke and drug delivery to the CNS through modifying the permeability of the blood brain barrier. The Company has initiated clinical trials, delivering a chemotherapeutic agent to primary brain tumor patients.)

Eratech srl

Eratech is a drug development company specialized in the field of inhalation drug delivery via nasal and pulmonary administration, for local and systemic therapies. Eratech offers to its clients the following selection of product development support services: Pharmacological-Toxicological, Pharmaceutical Development, Clinical Trials, Regulatory Affairs. nnn


Glycologic Limited is a company dedicated to the creation of nutritional, clinical nutrition and drug delivery systems based on carbohydrates which overcome the limitations of other technologies. The Company utilises the properties of carbohydrates to develop customised solutions to a wide variety of nutritional and pharmaceutical problems.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.